PharmaShots | Incisive News in 3 Shots

Subscribe Now

CANbridge

PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

October 14, 2023

CANbridge’ CAN108 (Livmarli) Receives TFDA Approval for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome in Taiwan

CANbridge’ CAN108 (Livmarli) Receives TFDA Approval for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome i...

October 10, 2023

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

March 17, 2023

CANbridge Reports P-I/II Study Results of CAN008 for Glioblastoma Multiforme

CANbridge Reports P-I/II Study Results of CAN008 for Glioblastoma Multiforme

March 17, 2023

CANbridge Reports NMPA Acceptance of NDA for AN108 to Treat Alagille Syndrome

CANbridge Reports NMPA Acceptance of NDA for AN108 to Treat Alagille Syndrome

January 18, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us